Pages that link to "Q33750454"
Jump to navigation
Jump to search
The following pages link to From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis (Q33750454):
Displaying 50 items.
- Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (Q21198697) (← links)
- Emerging Pharmacotherapies for Neurodevelopmental Disorders (Q24619170) (← links)
- Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target (Q27024547) (← links)
- The role of mTOR signaling in Alzheimer disease (Q28256247) (← links)
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1 (Q29615179) (← links)
- Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases. (Q30361244) (← links)
- Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders (Q30399814) (← links)
- Both maternal and pup genotype influence ultrasonic vocalizations and early developmental milestones in tsc2 (+/-) mice (Q30432308) (← links)
- A pulse rapamycin therapy for infantile spasms and associated cognitive decline (Q30501073) (← links)
- The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease (Q33914286) (← links)
- Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders (Q34024856) (← links)
- The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway (Q34261603) (← links)
- The small GTPase Rheb affects central brain neuronal morphology and memory formation in Drosophila (Q34427606) (← links)
- Genome-wide analysis of H4K5 acetylation associated with fear memory in mice (Q34910865) (← links)
- Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome (Q34999452) (← links)
- Sweet taste receptor signaling network: possible implication for cognitive functioning (Q35012275) (← links)
- Mutations causing syndromic autism define an axis of synaptic pathophysiology (Q35587150) (← links)
- Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist (Q35593184) (← links)
- Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons (Q35634446) (← links)
- Education of a child neurologist: developmental neuroscience relevant to child neurology (Q35789190) (← links)
- Above genetics: lessons from cerebral development in autism (Q35902641) (← links)
- Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration (Q36464286) (← links)
- Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation (Q36533150) (← links)
- Estradiol-induced object recognition memory consolidation is dependent on activation of mTOR signaling in the dorsal hippocampus (Q36626391) (← links)
- Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex (Q36731382) (← links)
- Sex differences in cerebellar synaptic transmission and sex-specific responses to autism-linked Gabrb3 mutations in mice (Q36932106) (← links)
- Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses (Q37068738) (← links)
- Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures (Q37579637) (← links)
- Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment (Q37703975) (← links)
- Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex (Q37774096) (← links)
- TOR on the brain. (Q37789848) (← links)
- The Genetics of Child Psychiatric Disorders: Focus on Autism and Tourette Syndrome (Q37801080) (← links)
- Advances in understanding behavioral phenotypes in neurogenetic syndromes (Q37803579) (← links)
- Behavioral profiles of mouse models for autism spectrum disorders (Q37844007) (← links)
- Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis (Q37931887) (← links)
- Epilepsy in four genetically determined syndromes of intellectual disability (Q37964799) (← links)
- Molecular therapies for tuberous sclerosis and neurofibromatosis (Q38006431) (← links)
- Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. (Q38027944) (← links)
- The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis (Q38028872) (← links)
- New models for considering the role of medication in the treatment and elucidation of the etiology of autism (Q38044266) (← links)
- Targeting the mTOR signaling network for Alzheimer's disease therapy (Q38121524) (← links)
- Neurobiology of autism gene products: towards pathogenesis and drug targets. (Q38178068) (← links)
- Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders (Q38263362) (← links)
- The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease (Q38400601) (← links)
- Neurological and neuropsychiatric aspects of tuberous sclerosis complex (Q38525506) (← links)
- Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics (Q38607739) (← links)
- PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. (Q38712234) (← links)
- Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (Q38777978) (← links)
- The mTOR signalling cascade: paving new roads to cure neurological disease (Q38875632) (← links)
- A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model (Q41211684) (← links)